There are several reports presenting data from mouse models that suggest that loading DCs with MUC1-based immunogens can result in tumour rejection in MUC1 transgenic (MUC1.Tg) mice (Koido et al, 2000; Chen et al, 2003). The gene discussed is MUC1; the disease is neoplasm.